Cell-mediated immunity is an important adaptive immune response to combat tumors in the cancer microenvironment [42], which includes the actions of Th cells (CD4+), CTL (CD8+), and Treg cells (CD4+/CD25+). This evidence concerns the gene CD4 and cancer.